1. Home
  2. ROIV vs PHYS Comparison

ROIV vs PHYS Comparison

Compare ROIV & PHYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROIV
  • PHYS
  • Stock Information
  • Founded
  • ROIV 2014
  • PHYS N/A
  • Country
  • ROIV United Kingdom
  • PHYS
  • Employees
  • ROIV N/A
  • PHYS N/A
  • Industry
  • ROIV Biotechnology: Pharmaceutical Preparations
  • PHYS
  • Sector
  • ROIV Health Care
  • PHYS
  • Exchange
  • ROIV Nasdaq
  • PHYS NYSE
  • Market Cap
  • ROIV 8.4B
  • PHYS 7.7B
  • IPO Year
  • ROIV N/A
  • PHYS N/A
  • Fundamental
  • Price
  • ROIV $11.83
  • PHYS $20.59
  • Analyst Decision
  • ROIV Strong Buy
  • PHYS
  • Analyst Count
  • ROIV 9
  • PHYS 0
  • Target Price
  • ROIV $17.69
  • PHYS N/A
  • AVG Volume (30 Days)
  • ROIV 4.5M
  • PHYS N/A
  • Earning Date
  • ROIV 11-12-2024
  • PHYS N/A
  • Dividend Yield
  • ROIV N/A
  • PHYS N/A
  • EPS Growth
  • ROIV N/A
  • PHYS N/A
  • EPS
  • ROIV 5.89
  • PHYS N/A
  • Revenue
  • ROIV $129,128,999.00
  • PHYS N/A
  • Revenue This Year
  • ROIV $48.37
  • PHYS N/A
  • Revenue Next Year
  • ROIV $13.76
  • PHYS N/A
  • P/E Ratio
  • ROIV $2.01
  • PHYS N/A
  • Revenue Growth
  • ROIV 145.68
  • PHYS N/A
  • 52 Week Low
  • ROIV $8.61
  • PHYS N/A
  • 52 Week High
  • ROIV $13.06
  • PHYS N/A
  • Technical
  • Relative Strength Index (RSI)
  • ROIV 51.97
  • PHYS 51.49
  • Support Level
  • ROIV $11.05
  • PHYS $20.55
  • Resistance Level
  • ROIV $12.05
  • PHYS $20.93
  • Average True Range (ATR)
  • ROIV 0.30
  • PHYS 0.17
  • MACD
  • ROIV -0.02
  • PHYS -0.04
  • Stochastic Oscillator
  • ROIV 61.86
  • PHYS 54.89

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About PHYS SPROTT PHYSICAL GOLD TRUST

Sprott Physical Gold Trust is a closed-end mutual fund trust. The company provides a secure, convenient, and exchange-traded investment alternative for investors interested in holding physical gold bullion without the inconvenience associated with direct investment in physical gold bullion. The company invests mainly in long-term holdings of unencumbered, fully allocated, physical gold bullion and does not and will not speculate about short-term changes in gold prices.

Share on Social Networks: